Company Filing History:
Years Active: 2019-2024
Title: The Innovative Contributions of Damien Bresson
Introduction
Damien Bresson is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of biotechnology. With a total of 5 patents to his name, Bresson has made remarkable strides in developing innovative therapeutic solutions.
Latest Patents
Among his latest patents, Bresson has developed anti-CD70 antibody drug conjugates. This invention relates to anti-CD70 antibodies and antibody drug conjugates that comprise at least one non-naturally-encoded amino acid. The disclosed αCD70 antibodies feature one or more non-naturally encoded amino acids, and the antibody drug conjugates are conjugated to one or more toxins. Additionally, methods for using these non-natural amino acid antibody drug conjugates are provided, including therapeutic, diagnostic, and other biotechnology applications. Another notable patent is for anti-OX40 binding proteins, which includes anti-OX40 antibodies and their antigen-binding portions. These antibodies or fragments are utilized in certain embodiments for the treatment of cancer.
Career Highlights
Throughout his career, Bresson has worked with several notable companies, including Ambrx, Inc. and Sorrento Therapeutics, Inc. His work in these organizations has contributed to advancements in therapeutic technologies and drug development.
Collaborations
Bresson has collaborated with esteemed colleagues such as Richard Spence Barnett and Ying Sun, further enhancing the impact of his innovative work in the biotechnology sector.
Conclusion
Damien Bresson exemplifies the spirit of innovation in biotechnology through his patents and collaborations. His contributions continue to pave the way for advancements in therapeutic solutions, particularly in cancer treatment.